Assessment of the diagnostic value of NT-proBNP in heart failure with preserved ejection fraction

Hayley Birrell1, Christopher Isles2, Omar Fersia3

  • 1Cardiac Physiologist.

PubMed

Insights

N-terminal pro-B-type natriuretic peptide (NT-proBNP) and age can predict diastolic dysfunction in suspected heart failure. Higher NT-proBNP thresholds maintain high negative-predictive values, suggesting tailored cut-offs could optimize echocardiogram demand.

Area of Science:

  • Cardiology
  • Medical Diagnostics

Background:

  • Heart failure with preserved ejection fraction (HFpEF) affects the aging population, causing significant morbidity and mortality.
  • Current guidelines use N-terminal pro-B-type natriuretic peptide (NT-proBNP) thresholds to trigger echocardiography for suspected heart failure (HF).
  • NT-proBNP levels increase with age and renal dysfunction, potentially increasing demand for echocardiography.

Purpose of the Study:

  • To evaluate the performance of NT-proBNP thresholds as a rule-out test for HFpEF.
  • To examine the relationship between NT-proBNP levels, age, and diastolic dysfunction.
  • To assess the impact of NT-proBNP thresholds on echocardiogram referral decisions.

Main Methods:

  • Analysis of NT-proBNP measurements and echocardiograms from 469 patients with suspected HF.
  • Statistical analysis to establish relationships between NT-proBNP, age, and diastolic dysfunction.
  • Calculation of negative-predictive values (NPVs) for various NT-proBNP cut-offs.

Main Results:

  • A significant association was found between NT-proBNP levels and diastolic dysfunction.
  • Both NT-proBNP levels and age were significant predictors of diastolic dysfunction.
  • High NPVs (>90%) were observed even at higher NT-proBNP cut-offs, indicating potential for optimized screening.

Conclusions:

  • NT-proBNP and age are valuable predictors of diastolic dysfunction in suspected HF.
  • Current NT-proBNP thresholds may lead to increased echocardiogram demand.
  • Utilizing higher, tailored NT-proBNP thresholds for specific subpopulations could improve diagnostic efficiency and reduce unnecessary echocardiograms.

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
213
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
6
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2